Israel Englander Windtree Therapeutics Inc Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.16 - $281.7 $10,608 - $18.7 Million	66,304 Added 366.0%	84,420 $14,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $306.0 $18,522 - $18.9 Million	-61,742 Reduced 77.31%	18,116 $5,000
Q2 2022 Aug 15, 2022	BUY	$0.38 - $1.14 $24,408 - $73,224	64,232 Added 411.06%	79,858 $33,000
Q1 2022 May 16, 2022	BUY	$0.94 - $1.6 $2,681 - $4,564	2,853 Added 22.34%	15,626 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.4 - $2.31 $142,381 - $234,929	-101,701 Reduced 88.84%	12,773 $21,000
Q2 2021 Aug 16, 2021	BUY	$1.68 - $2.79 $58,304 - $96,826	34,705 Added 43.51%	114,474 $262,000
Q1 2021 May 17, 2021	SELL	$2.14 - $6.18 $59,355 - $171,408	-27,736 Reduced 25.8%	79,769 $195,000
Q4 2020 Feb 16, 2021	SELL	$4.98 - $7.47 $220,135 - $330,203	-44,204 Reduced 29.14%	107,505 $552,000
Q3 2020 Nov 16, 2020	BUY	$5.5 - $9.9 $834,399 - $1.5 Million	151,709 New	151,709 $834,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $9.49M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.